X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54611) 54611
Publication (6415) 6415
Newsletter (2051) 2051
Book Chapter (576) 576
Book Review (490) 490
Newspaper Article (105) 105
Conference Proceeding (104) 104
Dissertation (88) 88
Magazine Article (52) 52
Book / eBook (36) 36
Reference (17) 17
Web Resource (15) 15
Government Document (13) 13
Data Set (8) 8
Trade Publication Article (8) 8
Streaming Video (3) 3
Paper (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (38410) 38410
index medicus (24560) 24560
acute myeloid-leukemia (22716) 22716
oncology (20496) 20496
hematology (20184) 20184
female (14641) 14641
male (14454) 14454
cancer (12899) 12899
leukemia (11633) 11633
adult (11034) 11034
middle aged (10863) 10863
acute myeloid leukemia (10146) 10146
animals (9889) 9889
chronic myeloid leukemia (8611) 8611
aged (8187) 8187
chronic myeloid-leukemia (8157) 8157
research (7170) 7170
adolescent (6000) 6000
mice (5799) 5799
chronic myelogenous leukemia (5480) 5480
apoptosis (5410) 5410
acute lymphoblastic-leukemia (5314) 5314
prognosis (5298) 5298
chemotherapy (5254) 5254
stem cells (5165) 5165
transplantation (5109) 5109
cell biology (5094) 5094
expression (5049) 5049
care and treatment (4801) 4801
mutation (4713) 4713
analysis (4372) 4372
hemic and lymphatic diseases (4320) 4320
myeloid leukemia (4225) 4225
biochemistry & molecular biology (4220) 4220
genetic aspects (4183) 4183
child (4162) 4162
acute myelogenous leukemia (4127) 4127
leukemia, myeloid, acute - genetics (4119) 4119
treatment outcome (3988) 3988
cell line, tumor (3961) 3961
gene expression (3840) 3840
myeloid-leukemia (3781) 3781
immunology (3704) 3704
health aspects (3649) 3649
antineoplastic agents - therapeutic use (3628) 3628
article (3465) 3465
therapy (3463) 3463
imatinib mesylate (3137) 3137
cells (3133) 3133
aged, 80 and over (3132) 3132
young adult (3126) 3126
bone marrow (3084) 3084
hematopoietic stem cells (3075) 3075
leukemia, myeloid, acute - pathology (3057) 3057
leukemia, myeloid, acute - drug therapy (3026) 3026
pharmacology & pharmacy (2974) 2974
proteins (2967) 2967
antineoplastic agents - pharmacology (2863) 2863
imatinib (2848) 2848
hematology, oncology and palliative medicine (2811) 2811
medicine, research & experimental (2720) 2720
child, preschool (2709) 2709
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (2704) 2704
risk factors (2703) 2703
genetics & heredity (2676) 2676
acute disease (2646) 2646
differentiation (2645) 2645
bone-marrow-transplantation (2636) 2636
survival (2616) 2616
myelodysplastic syndrome (2600) 2600
oncology, experimental (2563) 2563
flow cytometry (2554) 2554
aml (2552) 2552
myelodysplastic syndromes (2504) 2504
bcr-abl (2498) 2498
tumors (2353) 2353
antineoplastic combined chemotherapy protocols - therapeutic use (2350) 2350
signal transduction (2313) 2313
gene (2310) 2310
stem-cell transplantation (2305) 2305
apoptosis - drug effects (2298) 2298
leukemia, myelogenous, chronic, bcr-abl positive - genetics (2292) 2292
medicine & public health (2289) 2289
retrospective studies (2285) 2285
hematopoietic stem cell transplantation (2186) 2186
diagnosis (2158) 2158
genes (2152) 2152
transplantation, homologous (2116) 2116
patients (2114) 2114
leukemia, myeloid, acute - therapy (2078) 2078
benzamides (2041) 2041
remission induction (2017) 2017
tumor cells, cultured (2017) 2017
mutations (2013) 2013
in-vitro (2006) 2006
cell proliferation (1978) 1978
recurrence (1975) 1975
stem-cells (1972) 1972
infant (1966) 1966
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1957) 1957
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (54720) 54720
Chinese (1030) 1030
Japanese (847) 847
French (207) 207
German (196) 196
Russian (142) 142
Spanish (67) 67
Korean (58) 58
Polish (48) 48
Portuguese (23) 23
Hungarian (9) 9
Persian (9) 9
Czech (6) 6
Turkish (6) 6
Dutch (4) 4
Slovenian (4) 4
Serbian (3) 3
Arabic (2) 2
Italian (2) 2
Slovak (2) 2
Swedish (2) 2
Croatian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 05/2009, Volume 119, Issue 5, pp. 1109 - 1123
Imatinib mesylate (IM), a potent inhibitor of the BCR/ABL tyrosine kinase, has become standard first-line therapy for patients with chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | MALIGNANT GLIOMA-CELLS | BLAST CRISIS | CLINICAL RESISTANCE | BCR-ABL MUTATIONS | ENDOPLASMIC-RETICULUM | CYTOCHROME-C RELEASE | CASPASE ACTIVATION | IMATINIB RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Transcription Factor CHOP - genetics | Neoplastic Stem Cells - cytology | Gene Expression - drug effects | Calcium - metabolism | Gene Expression - genetics | Microtubule-Associated Proteins - metabolism | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Endoplasmic Reticulum - metabolism | Antineoplastic Agents - therapeutic use | Autophagy - physiology | Thiazoles - therapeutic use | Autophagy - drug effects | Chloroquine - pharmacology | Neoplastic Stem Cells - metabolism | RNA Interference | Endoplasmic Reticulum - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Macrolides - pharmacology | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Dasatinib | Chloroquine - therapeutic use | Piperazines - therapeutic use | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Mice, Inbred C3H | Xenograft Model Antitumor Assays | Fusion Proteins, bcr-abl - genetics | Animals | Cell Death - physiology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Macrolides - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Causes of | Physiological aspects | Genetic aspects | Chronic myeloid leukemia | Research | Drug therapy | Phagocytosis
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 3, pp. 452 - 458
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e30264
NK cells have therapeutic potential for a wide variety of human malignancies. However, because NK cells expand poorly in vitro, have limited life spans in... 
MOUSE NK CELLS | CELLULAR CYTOTOXICITY ADCC | ADOPTIVE TRANSFER | IN-VITRO EXPANSION | BIOLOGY | PERIPHERAL-BLOOD | ACUTE MYELOID-LEUKEMIA | CANCER-IMMUNOTHERAPY | CLINICAL-GRADE | CD8(+) T-CELLS | BLOOD MONONUCLEAR-CELLS | Cell Proliferation | Artificial Cells - immunology | Coculture Techniques | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Gene Expression Profiling | Interleukin-15 - immunology | Interleukins - metabolism | Flow Cytometry | T-Lymphocytes - metabolism | U937 Cells | Interleukins - immunology | Receptors, KIR - metabolism | Killer Cells, Natural - immunology | Membrane Proteins - metabolism | Telomere - genetics | Cell Line | Antigen-Presenting Cells - metabolism | Immunotherapy, Adoptive - methods | Cells, Cultured | Immunophenotyping | Membrane Proteins - immunology | Antigen-Presenting Cells - immunology | Artificial Cells - metabolism | Interleukin-15 - metabolism | K562 Cells | Cell Line, Tumor | T-Lymphocytes - immunology | Killer Cells, Natural - metabolism | Receptors, KIR - immunology | Antigens | Fc receptors | Telomeres | Killer cells | Health aspects | Immunotherapy | Cell proliferation | Lymphocyte receptors | Cell culture | Pediatrics | Senescence | Transplants & implants | Transcription | Toxicity | Adoptive immunotherapy | Erythrocytes | Multiple myeloma | Science | Clinical trials | Cytotoxicity | Leukocytes | Cancer therapies | NKG2 antigen | Cell growth | Lymphocytes | Interleukin 21 | Killer cell immunoglobulin-like receptors | Biocompatibility | Natural killer cells | Expansion | Killing | Cytomegalovirus | Cytokines | Dendritic cells | Secretion | Blood cells | T cell receptors | Tumor cell lines | Gene expression | Interleukin 15 | White blood cells | CD16 antigen | Biopsy | Antigen-presenting cells | Human performance | Ligands | Genetic engineering
Journal Article